X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
thrombosis (12) 12
cardiac & cardiovascular systems (10) 10
index medicus (10) 10
biodegradable polymer (8) 8
nobori stent (8) 8
drug-eluting stents (7) 7
nobori (7) 7
sirolimus (7) 7
bare-metal stents (6) 6
biolimus-eluting stent (6) 6
humans (6) 6
polymers (6) 6
everolimus-eluting stent (5) 5
myocardial-infarction (5) 5
comprehensive network metaanalysis (4) 4
drug-eluting stent (4) 4
female (4) 4
implantation (4) 4
implants (4) 4
male (4) 4
myocardial infarction (4) 4
optical coherence tomography (4) 4
stent (4) 4
stents (4) 4
xience (4) 4
artery-disease (3) 3
biodegradability (3) 3
cardiac patients (3) 3
clinical trials (3) 3
drug delivery (3) 3
heart (3) 3
heart diseases (3) 3
inflammation (3) 3
intervention (3) 3
leaders (3) 3
non-inferiority trial (3) 3
outcomes (3) 3
patients (3) 3
percutaneous coronary intervention (3) 3
polymer industry (3) 3
promus (3) 3
safety (3) 3
sirolimus - adverse effects (3) 3
surgical implants (3) 3
transluminal angioplasty (3) 3
trial (3) 3
absorbable implants (2) 2
aged (2) 2
analysis (2) 2
biodegradable plastics - therapeutic use (2) 2
biodegradable polymer-coated stent (2) 2
biodegradable polymers (2) 2
biodegradable-polymer (2) 2
biodegradation (2) 2
cardiology (2) 2
cardiovascular (2) 2
care and treatment (2) 2
clinical outcomes (2) 2
clinical-outcomes (2) 2
compare ii (2) 2
composite materials (2) 2
coronary artery disease (2) 2
coronary heart disease (2) 2
coronary stent (2) 2
coronary vessels (2) 2
coronary-artery-disease (2) 2
drug (2) 2
drug-eluting stents - adverse effects (2) 2
drug‐eluting stent (2) 2
follow-up (2) 2
infarction (2) 2
long-term outcomes (2) 2
medical research (2) 2
medicine (2) 2
medicine, experimental (2) 2
meta-analyses (2) 2
middle aged (2) 2
multidisciplinary sciences (2) 2
nobori biolimus-eluting stent (2) 2
noninferiority trial (2) 2
paclitaxel (2) 2
patient outcomes (2) 2
percutaneous coronary intervention - methods (2) 2
pharmacokinetics (2) 2
pooled analysis (2) 2
prospective studies (2) 2
prosthesis design (2) 2
randomization (2) 2
randomized controlled trials as topic (2) 2
risk (2) 2
risk factors (2) 2
science (2) 2
sirolimus - administration & dosage (2) 2
sirolimus - analogs & derivatives (2) 2
sirolimus - therapeutic use (2) 2
sites (2) 2
stent thrombosis (2) 2
treatment outcome (2) 2
vascular-responses (2) 2
abridged index medicus (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC: Cardiovascular Interventions, ISSN 1936-8798, 06/2017, Volume 10, Issue 12, pp. 1215 - 1221
Journal Article
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2017, Volume 10, Issue 12, pp. 1215 - 1221
Abstract Objectives This analysis investigates the 5-year outcomes of the biodegradable polymer biolimus-eluting stent (BP-BES) and durable polymer... 
Cardiovascular | everolimus-eluting stent(s) | Promus | Nobori | Xience | biodegradable polymer-coated stent(s) | biolimus-eluting stent(s)
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e78667
Journal Article
Expert Review of Medical Devices, ISSN 1743-4440, 2014, Volume 11, Issue 3, pp. 275 - 282
Despite first-generation drug-eluting stents (DES) dramatically reduced the need for repeat revascularization in patients undergoing percutaneous coronary... 
biolimus-eluting stent | Nobori stent | percutaneous coronary intervention | drug-eluting stent | biodegradable stent | BIODEGRADABLE POLYMER | MYOCARDIAL-INFARCTION | ENGINEERING, BIOMEDICAL | BARE-METAL STENTS | LONG-TERM OUTCOMES | COMPARE II | FOLLOW-UP | ENDOTHELIAL FUNCTION | ARTERY-DISEASE | SIROLIMUS
Journal Article
EUROINTERVENTION, ISSN 1774-024X, 10/2014, Volume 10, Issue 6, pp. 717 - 723
Aims: Biodegradable polymer-based drug-eluting stents are thought to be safer than durable polymer-based stents. However, the long-term vascular response... 
CARDIAC & CARDIOVASCULAR SYSTEMS | drug-eluting stents | biocompatibility | OPTICAL COHERENCE TOMOGRAPHY | THROMBOSIS | biodegradable polymer | NON-INFERIORITY TRIAL | BARE-METAL | FOLLOW-UP | RISK | NOBORI STENT | IMPLANTATION | COMPREHENSIVE NETWORK METAANALYSIS | SIROLIMUS
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 14997 - 9
Biodegradable polymer biolimus-eluting stents (BP-BES) are third-generation drug-eluting stents (DES) composed of biodegradable polymers that may improve... 
RANDOMIZED CONTROLLED-TRIALS | NOBORI STENT | THROMBOSIS | MULTIDISCIPLINARY SCIENCES | ACUTE MYOCARDIAL-INFARCTION | MECHANISMS | BIOLIMUS-ELUTING STENT | INTERVENTION | CORONARY-ARTERY-DISEASE | CLINICAL-OUTCOMES | SIROLIMUS | Myocardial infarction | Biodegradability | Mortality | Implants | Drug delivery | Stents | Thrombosis | Heart diseases
Journal Article
01/2017, ISBN 1118976037, 16
The Biolimus peculiar chemical structure consists of a 31‐membered triene macrolide lactone that preserves the core sirolimus ring structure with a... 
persistent inflammation | Nobori stent | biolimus stent | bare metal stent | BioFreedom stent | drug‐coated stent | sirolimus‐eluting stent | micro‐structured abluminal surface | biodegradable‐polymer coated device | BioMatrix stent
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.